Ads
related to: tecentriq immunotherapy- Dosing and Administration
Learn About Preparation, Dosage,
and Administration for KEYTRUDA.
- Ask Merck
Connect With a Merck Associate Now
or Schedule a Call.
- Clinical Data
View Clinical Data for
KEYTRUDA at the Official HCP Site.
- Safety Information
Access Safety Information for
KEYTRUDA at the Official HCP Site.
- Dosing and Administration
Search results
Roche's (RHHBY) Tecentriq Subcutaneous Gets Approval in the EU
Zacks via Yahoo Finance· 4 months agoRoche RHHBY announced that the European Commission has granted marketing authorization to...
Roche (RHHBY) Tecentriq SC Receives Positive CHMP Opinion
Zacks via Yahoo Finance· 6 months agoRoche RHHBY announced that the European Medicines Agency’s Committee for Medicinal Products for...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Amgen says Lumakras plus immunotherapy for lung cancer needs further study
Reuters via Yahoo News· 2 years agoA small study of Amgen Inc's Lumakras drug combined with immunotherapy found it helped 29% of...
Amgen's Lumakras/immunotherapy combo data held for August lung cancer meeting
Reuters via Yahoo News· 2 years ago(Reuters) -Early trial data on Amgen Inc's Lumakras was released on Tuesday by the World Conference...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 9 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Biotech Stocks Rally After Roche's (RHHBY) Accidental Data Leak
Zacks via Yahoo Finance· 9 months agoOn Aug 23, shares of several biotech companies rose after pharma-giant Roche‘s RHHBY stated that it...
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
Benzinga via Yahoo Finance· 2 years agoBioNTech SE (NASDAQ: BNTX) announced initial data from the Phase 1 study of mRNA-based...
Merck pays $680M for struggling cancer biotech Harpoon
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: Merck & Co. is beefing up its cancer pipeline, announcing Monday it will pay $680...
Ads
related to: tecentriq immunotherapy